120 related articles for article (PubMed ID: 2206948)
1. Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice.
Chauffert B; Pelletier H; Corda C; Solary E; Bedenne L; Caillot D; Martin F
Br J Cancer; 1990 Sep; 62(3):395-7. PubMed ID: 2206948
[TBL] [Abstract][Full Text] [Related]
2. Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.
Genne P; Dimanche-Boitrel MT; Mauvernay RY; Gutierrez G; Duchamp O; Petit JM; Martin F; Chauffert B
Cancer Res; 1992 May; 52(10):2797-801. PubMed ID: 1581892
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of amiodarone required for an in vivo modulation of anthracycline resistance.
Genne P; Coudert B; Pelletier H; Girardot C; Martin F; Chauffert B
Anticancer Res; 1989; 9(6):1655-9. PubMed ID: 2627117
[TBL] [Abstract][Full Text] [Related]
4. Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM.
Solary E; Velay I; Chauffert B; Bidan JM; Caillot D; Dumas M; Guy H
Cancer; 1991 Oct; 68(8):1714-9. PubMed ID: 1913513
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model.
Lehnert M; Dalton WS; Roe D; Emerson S; Salmon SE
Blood; 1991 Jan; 77(2):348-54. PubMed ID: 1670760
[TBL] [Abstract][Full Text] [Related]
6. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
Belhoussine R; Morjani H; Manfait M
Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
[TBL] [Abstract][Full Text] [Related]
7. Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft.
Plumb JA; Wishart GC; Setanoians A; Morrison JG; Hamilton T; Bicknell SR; Kaye SB
Biochem Pharmacol; 1994 Jan; 47(2):257-66. PubMed ID: 8304970
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes.
Hedman A; Meijer DK
J Pharm Sci; 1998 Apr; 87(4):457-61. PubMed ID: 9548899
[TBL] [Abstract][Full Text] [Related]
9. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
Lo YL; Liu Y; Tsai JC
Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
[TBL] [Abstract][Full Text] [Related]
10. Circumvention of inherent or acquired cytotoxic drug resistance in vitro using combinations of modulating agents.
Cadagan D; Merry S
Anticancer Res; 2013 Oct; 33(10):4381-7. PubMed ID: 24123006
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells.
Chauffert B; Rey D; Coudert B; Dumas M; Martin F
Br J Cancer; 1987 Aug; 56(2):119-22. PubMed ID: 3663463
[TBL] [Abstract][Full Text] [Related]
12. Quinine impairs quinidine clearance in rat perfused liver.
Mihaly GW; Scott H; Hyman MK; Morgan DJ; Smallwood RA
J Pharm Pharmacol; 1993 Mar; 45(3):215-7. PubMed ID: 8097780
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
Lo YL; Liu FI; Yang JM; Cherng JY
Anticancer Res; 2001; 21(1A):445-50. PubMed ID: 11299776
[TBL] [Abstract][Full Text] [Related]
14. Quinine circumvents the doxorubicin resistance of a multidrug resistant human leukemic cell-line, K562/DXR.
Solary E; Velay I; Chauffert B; Caillot D; Bidan JM; Dumas M; Casasnovas O; Guy H
Nouv Rev Fr Hematol (1978); 1990; 32(5):361-3. PubMed ID: 2099412
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.
Scheithauer W; Schenk T; Czejka M
Br J Cancer; 1993 Jul; 68(1):8-9. PubMed ID: 8318424
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of quinidine and quinine on liver microsome oxidation enzymes in man and rat.
Tu ZG; Zhao LL
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):541-4. PubMed ID: 9863152
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by basic drugs of digoxin secretion into human bile.
Hedman A
Eur J Clin Pharmacol; 1992; 42(4):457-9. PubMed ID: 1516611
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. I. Amrubicin accumulates to a lower level than doxorubicin or epirubicin.
Salvatorelli E; Menna P; Surapaneni S; Aukerman SL; Chello M; Covino E; Sung V; Minotti G
J Pharmacol Exp Ther; 2012 May; 341(2):464-73. PubMed ID: 22338033
[TBL] [Abstract][Full Text] [Related]
19. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.
del Pozo BF; Pérez-Vizcaíno F; Villamor E; Zaragozá F; Tamargo J
Br J Pharmacol; 1996 Jan; 117(1):105-10. PubMed ID: 8825350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
